Valneva SE
VALN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001836564
No open-market purchases or sales by Valneva SE insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $19.8M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Valneva SE changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 0 | 9 | +9 |
| Shares | 0 | 800.9K | +800.9K |
| Value | $0 | $21.1M | +$21.1M |
New holders (9)
Institutions that held Valneva SE at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vivo Capital, LLC | 400,000 | $10.5M | 0.46% |
| Citadel Advisors LLC | 195,000 | $5.14M | 0.01% |
| General American Investors Co Inc | 75,000 | $1.98M | 0.17% |
| CVI Holdings, LLC | 56,395 | $1.49M | 0.10% |
| Laurion Capital Management LP | 25,000 | $659.0K | 0.01% |
| Jane Street Group, LLC | 23,855 | $629.0K | 0.00% |
| Millennium Management LLC | 9,823 | $259.0K | 0.00% |
| Symmetry Peak Management LLC | 8,109 | $214.0K | 2.53% |
| Tudor Investment Corp Et Al | 7,700 | $203.0K | 0.00% |
Sold out (0)
Institutions that held Valneva SE at the end of Q1 2021 and filed for Q2 2021 without it.
None.